Nurix Therapeutics, Inc. NRIX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s total liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported total liabilities of $155.24M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s total liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s total liabilities increased by 15.7% year-over-year, from $134.13M to $155.24M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total liabilities has grown at a 7.1% compound annual growth rate (CAGR), from $106.07M to $149.39M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.